Semaglutide is one of the most clinically studied and prescribed GLP-1 receptor agonists in the world, with proven efficacy for both type 2 diabetes management and chronic weight loss. But getting the dosing right—particularly the titration schedule—is critical for both maximizing results and minimizing the gastrointestinal side effects that cause many patients to discontinue treatment prematurely. This guide walks through everything you need to know about semaglutide dosing, from week one through long-term maintenance.

How Semaglutide Works: A Quick Primer

Semaglutide is a GLP-1 (glucagon-like peptide-1) receptor agonist. It mimics the GLP-1 hormone naturally released from the gut after eating, producing several metabolic effects:

  • Stimulates insulin secretion in a glucose-dependent manner (reduces blood sugar after meals)
  • Suppresses glucagon release, which lowers baseline blood sugar
  • Slows gastric emptying, reducing the speed at which food enters the small intestine
  • Signals the hypothalamus to reduce appetite and increase feelings of fullness (satiety)

The appetite-suppression and satiety effects are what drive meaningful weight loss. In the landmark STEP 1 clinical trial, participants taking semaglutide 2.4 mg weekly (the Wegovy dose) lost an average of 14.9% of their body weight over 68 weeks when combined with diet and exercise—compared to 2.4% in the placebo group.

Semaglutide Formulations: Which Are You Taking?

There are three FDA-approved semaglutide products, and each has a distinct dosing schedule:

  • Ozempic (injectable, weekly): Indicated for type 2 diabetes. Available in 0.5 mg, 1 mg, and 2 mg weekly doses.
  • Wegovy (injectable, weekly): Indicated for chronic weight management. Uses a 5-step titration that ends at a maintenance dose of 2.4 mg/week.
  • Rybelsus (oral tablet, daily): Indicated for type 2 diabetes. Doses of 3 mg, 7 mg, and 14 mg.

This guide focuses primarily on injectable semaglutide used for weight management, as this is where the most clinical evidence exists and where dosing nuances have the greatest impact on outcomes.

Standard Semaglutide Dose Schedule (Wegovy / Weight Management)

The FDA-approved titration schedule for Wegovy is designed over approximately 17 weeks before reaching the full maintenance dose. The slow escalation allows your body to adapt to the medication and dramatically reduces the risk of severe nausea and vomiting.

Weeks 1–4: 0.25 mg/week

This is the starting dose and is considered a ramp-up phase rather than a therapeutic dose. At 0.25 mg, most patients experience minimal side effects. Weight loss at this stage is typically modest—the purpose is adaptation, not maximum effect. Do not attempt to skip this phase, even if you feel the dose is too low. Jumping ahead increases the risk of intolerable nausea.

Weeks 5–8: 0.5 mg/week

The first meaningful therapeutic dose. Many patients begin to notice appetite suppression during this phase. Nausea is most common in the first few days after each dose increase. Eating smaller meals, avoiding high-fat foods, and staying well hydrated can help manage these symptoms.

Weeks 9–12: 1.0 mg/week

Weight loss typically accelerates during this phase. Blood glucose control (in patients with diabetes) improves significantly. Side effects often stabilize as the body adapts. Some patients with strong tolerability may note their provider choosing to remain at this dose longer if further titration seems premature.

Weeks 13–16: 1.7 mg/week

The penultimate step. Most patients experience noticeable satiety between meals and a significant reduction in cravings. Energy intake naturally decreases. Constipation becomes a more common side effect than nausea at this stage for many patients—increasing fluid and fiber intake is recommended.

Week 17 Onward: 2.4 mg/week (Maintenance)

This is the target maintenance dose for weight management. Clinical trials show this is the dose at which the most robust weight loss occurs. The STEP 4 trial demonstrated that patients who reached 2.4 mg and continued treatment maintained significantly greater weight loss than those who discontinued—reinforcing that semaglutide works best as a long-term treatment, not a short-term fix.

If the 2.4 mg dose is not tolerated, guidelines allow patients to remain at 1.7 mg/week as a maintenance dose.

Ozempic Dosing Schedule (Diabetes Indication)

For patients prescribed Ozempic for type 2 diabetes, the titration is slightly different:

  • Weeks 1–4: 0.25 mg/week (initiation dose)
  • Weeks 5 and beyond: 0.5 mg/week (first maintenance dose)
  • If additional glycemic control needed after 4+ weeks at 0.5 mg: Increase to 1.0 mg/week
  • If further control needed: Increase to 2.0 mg/week (maximum Ozempic dose)

Notably, the maximum Ozempic dose (2.0 mg) is lower than the Wegovy maintenance dose (2.4 mg), which is one of the reasons Wegovy produces greater weight loss results.

What to Do If You Miss a Dose

Semaglutide has a long half-life of approximately 7 days, which is why once-weekly dosing works. If you miss a dose:

  • If it has been 5 days or fewer since your scheduled dose: Take the missed dose as soon as you remember and resume your regular weekly schedule.
  • If it has been more than 5 days: Skip the missed dose entirely and take your next dose on the regular scheduled day. Do not take two doses in one week.

Occasional missed doses are unlikely to significantly impact your progress, but consistency is key for optimal outcomes. Consider setting a weekly phone reminder on the same day each week.

Managing Side Effects During Dose Escalation

The most common semaglutide side effects are gastrointestinal: nausea, vomiting, diarrhea, and constipation. These are most pronounced during dose escalation and tend to improve within a few weeks at each new dose level. Evidence-based strategies to minimize side effects include:

  • Eat smaller, more frequent meals rather than large portions
  • Avoid high-fat, greasy, or spicy foods for the first 24–48 hours after a new dose
  • Stay well hydrated — dehydration worsens nausea
  • Inject in the evening so any peak nausea occurs during sleep
  • Avoid reclining immediately after eating to reduce reflux
  • Ginger tea or ginger chews may provide modest relief for nausea

If side effects are severe or persistent, your prescribing physician may recommend pausing the current dose for an additional 4 weeks before attempting the next increase. Never discontinue semaglutide abruptly without consulting your provider—weight regain often follows if treatment is stopped without a plan.

Who Should Not Use Semaglutide?

Semaglutide is not appropriate for everyone. Your physician will screen for contraindications including:

  • Personal or family history of medullary thyroid carcinoma (MTC) or Multiple Endocrine Neoplasia syndrome type 2 (MEN 2)
  • History of pancreatitis
  • Severe gastrointestinal disease
  • Pregnancy or breastfeeding
  • Type 1 diabetes or diabetic ketoacidosis

A thorough medical history during your consultation ensures semaglutide is safe for you to use.

Semaglutide Dosing for Weight Loss: Real-World Expectations

Clinical trial results represent average outcomes under controlled conditions. In real-world settings, individual results vary based on adherence, dietary changes, physical activity, baseline weight, and metabolic factors. However, the data consistently show:

  • Most patients begin to see measurable weight loss within the first 4–8 weeks of treatment
  • Weight loss typically continues for up to 68 weeks at the maintenance dose
  • Patients who combine semaglutide with dietary changes and physical activity lose significantly more weight than those relying on the medication alone
  • A plateau is normal around weeks 40–52; it does not mean the medication has stopped working

Getting Started with Semaglutide Through Truventa Medical

Beginning semaglutide requires a prescription from a licensed physician who has reviewed your medical history. At Truventa Medical, our online consultation process is streamlined and fully remote—no office visits required. Our board-certified providers are licensed in all 50 states, and our team will guide you through each step of your dosing journey, including regular check-ins to adjust your plan as needed.

Whether you're just starting to explore GLP-1 treatment or you've had difficulty managing side effects in the past, working with an experienced telehealth team ensures you have the clinical support to succeed.

Key Takeaways

  • The standard semaglutide titration for weight management spans 17 weeks, starting at 0.25 mg and ending at 2.4 mg/week.
  • Slow titration is essential—skipping steps increases side effect risk without improving outcomes.
  • Nausea is most common during dose increases and typically resolves within weeks.
  • Missing a dose within 5 days: take it. Beyond 5 days: skip and resume the next scheduled dose.
  • Long-term adherence combined with lifestyle changes produces the best results.